
Regentis Biomaterials Secures Japanese Patent, Bolstering Global IP and Manufacturing for GelrinC
Regentis Biomaterials' new Japanese patent allowance, following a US grant, protects its solvent-free manufacturing process for GelrinC, enhancing commercial viability in the global cartilage repair market.
Read full story

























